OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021

NEXT STORY
BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021
PREV STORY
G1 Therapeutics Announces Appointment of Andrew Perry as Chief Commercial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring’s Lead Asset, Plinabulin, Prevents Docetaxel Chemo-Induced-Neutropenia (CIN) Due to a Mechanism of Action Differentiated from G-CSF

Evidence of Neutrophil Demargination and Bone Marrow Transit Time Reduction by Plinabulin Presented at ...

author_avatar
NASDAQ Market News

Terveystalo Plc: Juha Tuominen, Chief Medical Officer of Terveystalo leaves the company

Terveystalo Plc Stock Exchange release 25 September 2018 at 9:00 a.m. EEST Juha Tuominen ...

author_avatar
NASDAQ Market News

Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023

GAITHERSBURG, Md., Jan. 29, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine ...

author_avatar
NASDAQ Market News